Product Description

This book is a comprehensive and accessible resource for primary care clinicians that provides multifaceted strategies necessary to treat hyperlipidemia, as well as tips for incorporating techniques into clinical practice. In addition to discussing pharmacologic treatment, the book includes a thorough review of popular diets and therapeutic foods, herbs, and vitamins. A section on evidence-based recommendations for treating special populations discusses approaches for elderly patients, women, elite athletes, and other populations with unique medical needs. Clinical case studies illustrate the principles introduced in the book. The text is complete with novel screening tools for real world risk assessment.

Product Description
Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Hyperlipidemia," including when used in literature (e.g. all authors that might have Hyperlipidemia in their name). As such, this book represents the largest compilation of timeline events associated with Hyperlipidemia when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry, physics, biology and other physical sciences. This "data dump" results in a comprehensive set of entries for a bibliographic and/or event-based timeline on the proper name Hyperlipidemia, since editorial decisions to include or exclude events is purely a linguistic process. The resulting entries are used under license or with permission, used under "fair use" conditions, used in agreement with the original authors, or are in the public domain. ... Read more

Product Description
This third edition of this well-received text continues to provide a state-of-the-art treatise on modern clinical practice relating to hyperlipidemia and lipoprotein disorders, conditions responsible for a huge amount of morbidity and mortality in Western countries and, increasingly, the developing world.The clinical evidence underlying the treatment of hyperlipidemia has burgeoned since the second edition published in 1994, with the publication of the results of many clinical trials on the new statin drugs, and teh subsequent appearance of national and international guidelines for cholesterol lowering in coronary prevention.There has also been considerable development in the definition of cardiovascular risk, and the methodology for identifying high-risk patients.

All of these aspects are addressed fully in the new edition.In addition, the book offers helpful summaries of the background biochemistry of lipoprotein metabolism and atherosclerosis where relevant, putting the subject in the context of its pathophysiology and epidemiology.The text relating to clinical aspects has a strong evidence base, reviewing, in particular, areas of uncertainty and controversy.

Drawing on the wealth of experience of the author, and representing his widely respected views on the subject, readers will find this comprehensive, well-referenced and accessible book invaluable. ... Read more

Product Description
A comprehensively illustrated guide to diagnosis, this atlas will assist cardiologists, endocrinologists, primary care physicians and other healthcare professionals in their daily task of making an accurate assessment of the patient and then formulating the most effective management program for each manifestation of this highly complex group of disorders.

This ground-breaking work--the first atlas of its kind--presents the science of lipid disorders in a clinical context by: illustrating the appearance of commonplace presentations as well as rare and complex disorders; relating observed signs of disease with underlying metabolic disease processes; providing comprehensive accounts of each condition's clinical characteristics permit early diagnosis of disease and more effective treatment; reviewing key investigative procedures including use of biomarkers, with notes on gene and protein structures including important mutations; including extensive references which clarify complexities of classification and nomenclature. ... Read more

Product Description
Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Hyperlipidemias," including when used in literature (e.g. all authors that might have Hyperlipidemias in their name). As such, this book represents the largest compilation of timeline events associated with Hyperlipidemias when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social sciences (linguistics, history, geography, economics, sociology, political science), business, computer science, literature, law, medicine, psychology, mathematics, chemistry, physics, biology and other physical sciences. This "data dump" results in a comprehensive set of entries for a bibliographic and/or event-based timeline on the proper name Hyperlipidemias, since editorial decisions to include or exclude events is purely a linguistic process. The resulting entries are used under license or with permission, used under "fair use" conditions, used in agreement with the original authors, or are in the public domain. ... Read more

Product Description
This digital document is an article from Alcohol Research & Health, published by U.S. Government Printing Office on January 1, 1999. The length of the article is 1086 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: ALCOHOL'S INFLUENCES ON VARIOUS DISEASE STATES.(medical conditions, such as diabetes and hyperlipidemia can be worsened by the use of alcohol)
Author: Ron Weathermon
Publication: Alcohol Research & Health (Refereed)
Date: January 1, 1999
Publisher: U.S. Government Printing Office
Volume: 23Issue: 1Page: 52

Distributed by Thomson Gale ... Read more

Product Description
In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing.This book was created for medical professionals, students, and members of the general public who want to conduct medical research using the most advanced tools available and spending the least amount of time doing so. ... Read more

Product Description
Univ. of Padua, Italy. Proceedings of the 8th European Symposium on Metabolism, held in Padua, Italy, on October 2-5, 2002. ... Read more

Product Description
This volume contains the presentations given during the 6th European Symposium on Metabolism by the invited speakers, and gives an up-to-date reflection of current data on diabetes, obesity, lipid metabolism and their interrelationships. The book is a comprehensive treatise of the three most important aspects of the human metabolism, and contains selected aspects of new developments on the therapy of the plurimetabolic syndrome, or insulin resistance syndrome. ... Read more

Product Description
This handbook provides a crisp and accurate summary of our current knowledge of hyperlipidemias. The authors outline a coherent pathophysiologic structure on which to build a sound diagnostic and clinical approach. They then offer practical, evidence-based solutions to routine problems encountered in their clinical management. This fully updated edition of Fast Facts - Hyperlipiemia will therefore be invaluable to a broad range of healthcare professionals, from primary care physicians to specialists. ... Read more

Product Description
People have always been interested in food as anecessity for survival, source of pleasure andcomfort, way of socializing and pleasing theappetite. Recently there has been a growing interest among people in consumption of foods that provideadditional health, medicinal, physiological andnutraceutical benefits beyond their originalnutritive value in an attempt to reduce the risk ofdeveloping chronic diseases. This in turn hasinspired nutritionists in being more activelyinvolved in developing what is now known asfunctional food, achieved by adding nutrients andhealth enhancing food bioactive compounds to thenatural food item. This book, which is the author'sMasters Degree dissertation, investigates thepossibility of incorporating both plant sterols andglucomannan in granola bars and testing their health benefits especially in people with Type 2 diabetes and hyperlipidemia. If proven effective, this combination may contribute to reducing risk of disease and consumption of medication. This book describes in addition to the thorough literature review of plant sterols and glucomannan, the clinical trial conducted to test their effect. ... Read more

Product Description
Question: A 46-year-old man with newly diagnosed hepatitis C and normal transaminase levels has a low-density lipoprotein cholesterol (LDL-C) concentration of 178 mg/dL (4.60 mmol/L). Would it be appropriate to start a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor ("statin") in such a patient? ... Read more

Product Description
Abstract: Coronary artery disease remains the No. 1 killer of both men and women in the United States. The correlation with hyperlipidemia is alarmingly clear: More than half of cases of heart disease are attributable to lipid abnormalities. The goal of this symposium is to emphasize the importance of controlling hyperlipidemia to reduce the incidence of heart disease. ... Read more